Pills, Plants, and Brainwaves: Three Paths to a Better Brain

Three Bets on the Same Brain

Right now, somewhere in the world, three people are trying to make their brains work better.

The first person is swallowing a white powder dissolved in water. It's piracetam, a synthetic compound invented in 1964 by a Romanian chemist who was trying to create a better sleeping pill and accidentally stumbled onto something that seemed to sharpen cognition instead. This person found it on an online vendor after reading a Reddit thread with 400 upvotes and a title promising "the clearest thinking of my life."

The second person is taking a capsule of ashwagandha root extract. The plant has been used in Ayurvedic medicine for over 3,000 years, and a handful of modern clinical trials suggest it lowers cortisol and reduces stress. This person heard about it from a podcast host who described it as "nature's chill pill."

The third person hasn't swallowed anything. They're sitting at their desk wearing a device with eight electrodes on their head, watching a real-time visualization of their own brainwave activity. When their focus drifts, the signal changes. When they pull their attention back, the signal responds. They're training their brain the same way you'd train a muscle, through repetition and feedback, without altering a single molecule of their neurochemistry.

Three completely different philosophies. Three different theories of what's wrong and how to fix it. And here's the part that should bother you: most people pick one of these approaches based on a podcast recommendation, a subreddit, or a friend's anecdote, without ever comparing the actual evidence behind them.

So let's do that. Let's compare them properly.

The Racetam Gamble: Synthetic Molecules with an Identity Crisis

Piracetam has one of the strangest origin stories in pharmacology. In 1964, Corneliu Giurgea at the Belgian pharmaceutical company UCB was working on derivatives of GABA, the brain's primary inhibitory neurotransmitter. He was looking for a sedative. What he got instead was a compound that seemed to do the opposite: in animal studies, piracetam appeared to enhance memory and learning without any of the stimulant effects you'd expect from a cognitive enhancer.

Giurgea was so intrigued that he coined an entirely new word for it. He called it a "nootropic," from the Greek noos (mind) and tropein (to turn). A mind-turner.

The racetam family has since grown to include aniracetam, oxiracetam, pramiracetam, and phenylpiracetam, among others. The newest and most potent member of the extended family is Noopept (technically a peptide rather than a true racetam, but pharmacologically related and almost always discussed alongside them). Each varies in potency, half-life, and subjective effects, but they share a common molecular backbone and a common mystery.

Here's the weird part: after more than 60 years, nobody is entirely sure how racetams work.

The leading theories involve modulation of acetylcholine receptors (which is why many racetam users co-supplement with choline), increased blood flow to the brain, enhanced communication between the brain's two hemispheres, and allosteric modulation of AMPA glutamate receptors. That last one is the most scientifically interesting. AMPA receptors play a central role in synaptic plasticity, the process by which connections between neurons strengthen or weaken in response to experience. If racetams genuinely enhance AMPA receptor function, they could theoretically improve learning at the hardware level.

That's the theory. Now for the reality.

What the Evidence Actually Shows

The clinical evidence for racetams is a patchwork of small studies, conflicting results, and a frustrating lack of large-scale, well-designed trials in healthy adults. Here's what we know:

Piracetam has the largest body of research, but most of it focuses on elderly populations with cognitive decline or dementia. A 2002 Cochrane review examined 19 studies of piracetam for dementia and concluded that while some individual trials showed benefits, the overall evidence was insufficient to support its use. Studies in healthy young adults are sparse and inconclusive.

Aniracetam has shown anxiolytic (anxiety-reducing) effects in animal models, but human clinical trials are limited. A few small studies suggest it may improve verbal fluency and subjective well-being, but the sample sizes are too small to draw reliable conclusions.

Noopept has generated the most excitement in online nootropic communities. It's roughly 1,000 times more potent by weight than piracetam (meaning effective doses are measured in milligrams rather than grams). Animal studies have shown improvements in memory consolidation and retrieval. But the human evidence? Mostly from Russian clinical trials with methodological limitations that make Western researchers uncomfortable.

And that brings us to the side effect question. Commonly reported side effects include headaches (the most frequent complaint, often attributed to choline depletion), insomnia, irritability, and GI discomfort. Most are mild. But here's what should give you pause: the long-term safety data simply doesn't exist. Nobody has studied what happens when a healthy 28-year-old takes piracetam every day for five years. If you're doing that, you are the study.

The Adaptogen Approach: Ancient Plants, Modern Stress

Adaptogens represent a fundamentally different philosophy. Where racetams try to enhance cognition directly by modulating neurotransmitter systems, adaptogens take an indirect route. They target your stress response, operating on the theory that a less stressed brain is a better-performing brain.

The term "adaptogen" was coined in 1947 by Soviet scientist Nikolai Lazarev, who defined it as a substance that increases the body's resistance to stress in a non-specific way. The concept was further developed by his student Israel Brekhman, who established three criteria that a true adaptogen must meet: it must be non-toxic at normal doses, it must produce a non-specific resistance to stress, and it must have a normalizing effect on physiology (meaning it pushes your system toward balance rather than pushing it in one direction).

The two most studied adaptogens for cognitive performance are ashwagandha and rhodiola rosea.

Ashwagandha: The Cortisol Regulator

Ashwagandha (Withania somnifera) works primarily through modulation of the HPA axis, the hypothalamic-pituitary-adrenal axis, which is your body's central stress response system. When you perceive a threat (real or imagined, physical or psychological), the hypothalamus signals the pituitary gland, which signals the adrenal glands to pump out cortisol. Cortisol is useful in short bursts. It sharpens your senses, mobilizes energy, and prepares you for action.

The problem is that modern life keeps this system activated chronically. Your HPA axis evolved for tigers and famine. It's being triggered by Slack notifications and quarterly reviews. Chronically elevated cortisol impairs hippocampal function (hurting memory), disrupts prefrontal cortex activity (reducing focus and executive function), and promotes neuroinflammation.

Ashwagandha appears to dampen this chronic activation. A well-designed 2012 study published in the Indian Journal of Psychological Medicine gave 64 adults with chronic stress either 300mg of ashwagandha root extract (KSM-66) twice daily or placebo for 60 days. The ashwagandha group showed a 27.9% reduction in serum cortisol levels compared to a 7.9% reduction in the placebo group. They also reported significantly lower stress, anxiety, and depression scores.

A 2019 study in Cureus found that 240mg of ashwagandha daily for 60 days improved reaction time and cognitive task performance in healthy adults compared to placebo. The effect sizes were modest but statistically significant.

Rhodiola Rosea: The Fatigue Fighter

Rhodiola takes a slightly different path. Native to cold, mountainous regions of Europe and Asia, this plant appears to modulate multiple neurotransmitter systems, including serotonin, dopamine, and norepinephrine, while also exhibiting antioxidant and anti-inflammatory properties.

The best evidence for rhodiola is in the domain of mental fatigue. A 2012 systematic review in BMC Complementary and Alternative Medicine examined 11 clinical trials and concluded that rhodiola demonstrated consistent benefits for physical and mental fatigue, with a favorable safety profile. A 2000 study on physicians during night shifts found that rhodiola improved cognitive test scores compared to placebo during the first two weeks of supplementation.

The Adaptogen Tradeoff

Adaptogens have better safety profiles than racetams. They've been used for centuries (millennia, in the case of ashwagandha), and modern studies consistently report minimal side effects at standard doses. The evidence base is growing, and several well-designed trials support their use for stress reduction and, indirectly, cognitive performance.

But "indirectly" is the key word. Adaptogens don't enhance cognition the way a stimulant does. They lower the floor of stress-related cognitive impairment. If chronic stress is dragging your focus down from a 9 to a 5, an adaptogen might bring you back up to a 7. If you're already calm and unstressed, the cognitive benefits may be negligible. They restore rather than enhance.

And there's a measurement problem. How do you know if ashwagandha is actually improving your focus, or if you just feel like it is because you're less anxious? Subjective self-report is notoriously unreliable for assessing cognitive performance. You need an objective measure. You need to see what your brain is actually doing.

Which brings us to the third approach.

EEG Neurofeedback: Training the Brain Without Changing Its Chemistry

Neurofeedback flips the entire cognitive enhancement paradigm on its head. Instead of putting something into your brain (a molecule, an extract, a compound), it works with what's already there. The principle is simple and, once you understand it, kind of elegant.

Your brain produces electrical patterns that correspond to different cognitive states. Focus, relaxation, mind-wandering, deep concentration: each has a measurable electrical signature. EEG can detect these patterns in real time. If you show someone their own brainwave data as it happens, and reward them when the pattern shifts toward the desired state, their brain learns to produce that state more reliably.

This is operant conditioning applied to neural oscillations. B.F. Skinner, meet Hans Berger.

Brainwave data, captured at 256Hz across 8 channels, processed on-device. The Crown's open SDKs let developers build brain-responsive applications.

Explore the Crown

The clinical literature on neurofeedback is more mature than most people realize. It's been studied since the 1960s, when Dr. Barry Sterman at UCLA discovered that cats trained to increase their sensorimotor rhythm (SMR, a specific EEG frequency around 12-15Hz) became resistant to seizure-inducing chemicals. This led to decades of research on neurofeedback for epilepsy, ADHD brain patterns, anxiety, and cognitive performance.

A 2014 meta-analysis published in European Child and Adolescent Psychiatry examined 13 randomized controlled trials of neurofeedback for ADHD and found significant improvements in inattention and impulsivity. A 2019 review in Applied Psychophysiology and Biofeedback concluded that neurofeedback produces "medium to large effects on attention" that persist after training ends.

That persistence is the crucial distinction. When you stop taking piracetam, any cognitive effects disappear. When you stop taking ashwagandha, your cortisol creeps back up. But when you complete a course of neurofeedback training, the neural patterns you've strengthened tend to stick. Your brain has literally learned a new way of operating.

The Crown as a Neurofeedback Platform

The Neurosity Crown brings clinical-grade neurofeedback out of the clinic and into your daily life. Eight EEG channels positioned at CP3, C3, F5, PO3, PO4, F6, C4, and CP4, covering all cortical lobes. The on-device N3 chipset processes your brainwaves at 256Hz and computes real-time focus and calm scores without sending your data to the cloud.

But here's what makes the Crown uniquely interesting in the context of cognitive enhancement: it's not just a training tool. It's a measurement tool. And that distinction matters enormously.

If you're taking piracetam and you think it's helping your focus, the Crown can show you whether your brainwave patterns are actually shifting toward the high-beta, low-theta signature associated with sustained attention. If you've been taking ashwagandha for a month and you feel calmer, the Crown can show you whether your alpha-to-beta ratios have actually changed.

In other words, the Crown can audit the other two approaches. It's both a competitor and a judge.

The Comparison: Everything Side by Side

Now let's lay these three approaches next to each other and compare them across the dimensions that actually matter.

A few things jump out from this comparison.

The evidence gap. Racetams have been around for 60 years and still lack the kind of strong, large-scale evidence that would make a skeptical scientist comfortable recommending them. Adaptogens are in better shape, with a growing body of well-designed trials, but they're still playing catch-up. Neurofeedback has the deepest clinical literature of the three, partly because it's been studied since the 1960s and partly because it's easier to design controlled studies for (you can create convincing sham neurofeedback for placebo controls).

The measurement problem. This might be the single most important difference. With racetams and adaptogens, you're essentially guessing whether they work. You take the substance, you go about your day, and you try to introspect on whether your cognition feels different. But humans are terrible at objectively assessing their own cognitive performance. The placebo effect is real, expectation effects are real, and confirmation bias is devastating when you've spent money on something and want it to work.

Neurofeedback, particularly through a device like the Crown, solves this problem by definition. The data is the training. You can see, in real time, whether your brain is producing the patterns associated with the cognitive state you want.

The side effect asymmetry. Racetams carry real risks, including known short-term side effects and unknown long-term ones. Adaptogens are generally well-tolerated but can interact with medications and aren't suitable for everyone (pregnant women, people with autoimmune conditions, and those on thyroid medication should avoid ashwagandha, for example). EEG neurofeedback has no chemical side effects. You're not introducing anything into your body. You're training what's already there.

The Hidden Variable Nobody Talks About

Here's something that rarely comes up in nootropic discussions: individual neurochemistry varies enormously. Your brain's baseline levels of acetylcholine, cortisol, dopamine, and serotonin are different from mine. Your receptor density is different. Your enzyme activity is different. Your gut microbiome (which affects the absorption and metabolism of every oral supplement you take) is different.

This means that a racetam that works beautifully for one person might do absolutely nothing for another, or worse, cause side effects without benefits. Same for adaptogens. The dose-response curve is unique to every brain.

And here's the part that should really make you think: without objective measurement, you'll never know which category you fall into.

This is the "I had no idea" moment for most people who start using EEG. They've been taking a nootropic stack for months, absolutely convinced it's working, and then they put on a Crown and run a baseline session. And the data shows... nothing. No statistically meaningful difference in their brainwave patterns compared to days when they didn't take anything.

Or the opposite happens. Someone dismisses adaptogens as "just herbs," starts tracking their brainwaves, takes ashwagandha for a month, and watches their alpha power during rest periods increase measurably. The data doesn't care about your priors.

The Sustainability Question

Let's zoom out and think about these three approaches over a longer time horizon. Say five years.

With racetams, you're on the hook for continuous use. You need to keep buying the powder or capsules, keep taking them daily, and keep hoping that the long-term safety data (which doesn't exist yet) eventually comes back clean. If you stop taking them, any effects disappear. You've built a dependency on an external molecule.

With adaptogens, the picture is slightly better. Traditional use suggests long-term safety, and some benefits (like improved stress resilience) may partially persist after discontinuation. But you're still relying on a daily supplement for ongoing effects.

With neurofeedback, the cost structure is fundamentally different. You buy a device once. You train with it over weeks or months. The neural patterns you develop become part of your brain's repertoire. You can continue training to deepen the effects or maintain them, but the core learning persists even during breaks. It's more like learning to ride a bicycle than like taking a painkiller. The skill stays with you.

There's a word for this difference in sustainability: agency. Racetams and adaptogens make you dependent on a substance. Neurofeedback makes you better at being you.

So Which One Should You Choose?

This is the part where most comparison articles give you a wishy-washy "it depends on your goals" answer and call it a day. I'm going to be more direct.

If your cognitive performance is suffering because of chronic stress, and you've confirmed this with a healthcare provider, adaptogens like ashwagandha have reasonable evidence behind them and a solid safety profile. They're not magic. They won't make you smarter. But they may remove the neurochemical obstacle that's keeping you from performing at your baseline. Think of them as clearing the fog, not sharpening the lens.

If you're drawn to racetams, be honest with yourself about the evidence. You're entering gray-market pharmacology with limited clinical backing. That's your right. But at minimum, you should be measuring the effects objectively rather than relying on subjective self-assessment. Otherwise, you're spending money on a compound and then using the least reliable instrument possible (your own perception) to judge whether it's working.

If you want a cognitive enhancement approach that has strong clinical evidence, zero chemical side effects, lasting results, and the ability to objectively measure its own effectiveness, EEG neurofeedback is the only option in this comparison that checks all four boxes.

And if you're taking racetams, adaptogens, or anything else and you want to know whether they're actually changing your brain activity or just changing your expectations, the Neurosity Crown turns that question from philosophical to empirical. Eight channels. 256 samples per second. Real-time data that doesn't care what you believe.

The Question Worth Sitting With

We've spent this entire article comparing three approaches to making your brain work better. But here's a question that cuts deeper than any comparison table.

Why do we reach for a pill before we reach for a mirror?

The impulse to swallow something, to add a chemical to our bloodstream and hope it optimizes our cognition, is deeply ingrained. We do it with caffeine every morning without thinking about it. We do it with supplements, medications, and increasingly with synthetic nootropics that live in regulatory gray zones.

But the brain is not a car running on the wrong fuel. It's not a machine with a chemical deficit that needs correcting. It's a living, adaptive organ that rewires itself in response to experience. Every focused work session you've ever had physically changed the structure of your neural connections. Every skill you've ever learned was written into your brain through the same mechanism that neurofeedback uses: repeated activation of specific neural patterns until they become the path of least resistance.

You don't need to alter your neurochemistry to think better. You need to see what your brain is already doing and train it to do more of what works.

That's not a philosophy. It's neuroscience. And for the first time in history, the tools to do it are sitting on your desk, not locked in a clinical lab.

The question isn't which pill to take. The question is whether you're willing to look at the data.